Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institu- tion and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curely-locked area as per Protocol require- ments; (iii) will use Study Drug only for Study purposes and according to the Pro- tocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the 1.7 Hodnocený přípravek.
Appears in 2 contracts
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institu- tion Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curelysecurely-locked area as per Protocol require- mentsrequirements; (iii) will use Study Drug only for Study purposes and according to the Pro- tocolProtocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the 1.7 Hodnocený přípravekStudy Drug or any portion thereof to any third party without first obtaining written approval from Idorsia.
Appears in 2 contracts
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institu- tion and Investigator; Institution (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curely-locked area as per Protocol require- mentsrequirements; (iii) will use Study Drug only for Study purposes pur- poses and according to the Pro- tocolProtocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) Investigator will not dispense expired Study Drug to Subjects; and (vi) will not transfer the 1.7 Hodnocený přípravekStudy Drug or any portion thereof to any third party without first obtaining written approval from Idorsia.
Appears in 1 contract
Samples: Institution Agreement
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no costcost at the appropriate intervals for the proper conduct of the clinical trial. Institu- tion Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curely-securely- locked area as per Protocol require- mentsrequirements; (iii) will use Study Drug only for Study purposes and according to the Pro- tocolProtocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the 1.7 Hodnocený přípravek.Study Drug or any portion thereof to 1.7
Appears in 1 contract
Samples: Clinical Trial Agreement